Richard Scott Struthers Transaction History

Date Transaction Value Shares Traded Form
Feb 12 2024
SELL
Bona fide gift
-
60,000
Feb 12 2024
BUY
Bona fide gift
-
60,000
Jul 13 2023
SELL
Open market or private sale
$288,094 $20.35 p/Share
14,157
Jul 12 2023
SELL
Open market or private sale
$231,128 $20.17 p/Share
11,459
Jul 11 2023
SELL
Open market or private sale
$491,093 $20.14 p/Share
24,384
Jun 16 2023
SELL
Open market or private sale
$1,040,499 $20.81 p/Share
50,000
Apr 13 2022
SELL
Open market or private sale
$3,672,653 $26.49 p/Share
138,643
Apr 05 2022
SELL
Open market or private sale
$541,186 $25.34 p/Share
21,357
Sep 07 2021
SELL
Open market or private sale
$750,000 $25.0 p/Share
30,000
Dec 02 2020
BUY
Open market or private purchase
$12,600 $12.6 p/Share
1,000
Jul 16 2020
SELL
Open market or private sale
$253,050 $14.46 p/Share
17,500
Jul 15 2020
SELL
Open market or private sale
$267,750 $15.3 p/Share
17,500
Aug 05 2019
BUY
Exercise of conversion of derivative security
$19,100 $1.91 p/Share
10,000
May 08 2019
BUY
Bona fide gift
-
1,215,805
RSS

Richard Scott Struthers

President & CEO
San Diego, CA

Track Institutional and Insider Activities on CRNX

Follow Crinetics Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRNX shares.

Notify only if

Insider Trading

Get notified when an Crinetics Pharmaceuticals, Inc. insider buys or sells CRNX shares.

Notify only if

News

Receive news related to Crinetics Pharmaceuticals, Inc.

Track Activities on CRNX